The association of family history with the risk of lung cancer: a pooled analysis of case-control studies 10.55131/jphd/2025/230323
Article Sidebar
Main Article Content
Abstract
The risk of lung carcinoma is influenced by genetic predisposition and other risk factors. This study aimed to explore the association between a family history of any type of cancer and the risk of lung carcinoma through a pooled analysis of case-control studies. A systematic literature search was performed across Google Scholar, PubMed, and Science Direct up to January 31, 2024. Eight observational case-control studies met the inclusion criteria, which required multivariate logistic regression analysis and a focus on familial cancer history. Using Review Manager software, pooled estimates and 95% confidence intervals were calculated. Out of 603 identified studies, eight were included. The meta-analysis found that individuals with a family history of cancer had a significantly higher risk of lung cancer (aOR = 1.64; 95% CI = 1.17–2.29; p = 0.004). These findings highlight the need for targeted screening and early detection strategies for high-risk individuals.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
GLOBOCAN. Cancer Today [Internet]. 2024 [cited 2024 Jan 20]. Available from: https://gco.iarc.fr
Bates JHT, Hamlington KL, Garrison G, Kinsey CM. Prediction of lung cancer risk based on age and smoking history. Comput Methods Programs Biomed. 2022 Apr;216:106660.
Tolwin Y, Gillis R, Peled N. Gender and lung cancer-SEER-based analysis. Ann Epidemiol. 2020 Jun;46:14–9.
Stapelfeld C, Dammann C, Maser E. Sex-specificity in lung cancer risk. Int J cancer. 2020 May;146(9):2376–82.
Siegfried JM. Sex and Gender Differences in Lung Cancer and Chronic Obstructive Lung Disease. Endocrinology. 2022 Feb;163(2).
Gasperino J. Gender is a risk factor for lung cancer. Med Hypotheses. 2011 Mar;76(3):328–31.
Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J. 2014; 20(4):237–45.
Cannon-Albright LA, Carr SR, Akerley W. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2019 Jul;14(7):1184–91.
Li D, Shi J, Liang D, Ren M, He Y. Lung cancer risk and exposure to air pollution: a multicenter North China case-control study involving 14604 subjects. BMC Pulm Med. 2023 May;23(1):182.
Singh S, Pavesi F, Steiling K, Asokan S, Espinosa C, Cabral HJ, et al. Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort. Clin Lung Cancer. 2022 Mar;23(2):e165–70.
Yoshida K, Takizawa Y, Nishino Y, Takahashi S, Kanemura S, Omori J, et al. Association between family history of cancer and lung cancer risk among Japanese men and women. Tohoku J Exp Med. 2019;247(2):99–110.
Yin X, Chan CPY, Seow A, Yau WP, Seow WJ. Association between family history and lung cancer risk among Chinese women in Singapore. Sci Rep. 2021 Nov;11(1):21862.
Xu CR, Lin H, Su J, Zhang XC, Huang YS, Yang XN, et al. Familial association of lung cancer with liver cancer in first-degree relatives. Cancer Manag Res. 2019;11:5813–9.
Li J, Li C, Cheng B, He J, Liang W. The Relative Impact of Family History of Different Cancers on Lung Cancer Risk. J Thorac Oncol [Internet]. 2019; 14(11):e248–9. Available from: https://doi.org/10.1016/j.jtho.2019.06.012
Hemminki K, Li X. Familial risk for lung cancer by histology and age of onset: evidence for recessive inheritance. Exp Lung Res. 2005 Mar;31(2):205–15.
Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, Jonsson HH, Kristjansson K, Arnason S, et al. Familial risk of lung carcinoma in the Icelandic population. JAMA. 2004 Dec;292(24):2977–83.
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Poznan, Poland). 2021;25(1):45–52.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
Lakkis NA, Musharafieh UM, Issa HG, Osman MH. Lung Cancer and Risk Factors in Lebanon: Epidemiology, Temporal Trends, and Comparison to Countries From Different Regions in the World. Cancer Control. 2023;30:1073274823 1169596.
Wang X, Qian ZM, Zhang Z, Cai M, Chen L, Wu Y, et al. Population attributable fraction of lung cancer due to genetic variants, modifiable risk factors, and their interactions: a nationwide prospective cohort study. Chemosphere. 2022 Aug;301:134773.
Mansour R, Al-Ani A, Al-Hussaini M, Abdel-Razeq H, Al-Ibraheem A, Mansour AH. Modifiable risk factors for cancer in the Middle East and North Africa: a scoping review. BMC Public Health. 2024 Jan;24(1):223.
Lichtenstein P, Holm N V, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000 Jul;343(2):78–85.
Braun MM, Caporaso NE, Page WF, Hoover RN. The genetic component of lung cancer: a cohort study of twins. Lancet (London, England). 1994 Aug; 344(8920):440–3.
Ni CH, Wang MT, Lu YQ, Zheng W, Chen C, Zheng B. Association between a family history of cancer and multiple primary lung cancer risks: a population-based analysis from China. BMC Pulm Med. 2023 Oct;23(1):415.
Turati F, Edefonti V, Bosetti C, Ferraroni M, Malvezzi M, Franceschi S, et al. Family history of cancer and the risk of cancer: A network of case-control studies. Ann Oncol. 2013; 24(10):2651–6.
Lynch TJ, Bell DW, Sordella R., Gurubhagavatula S., Okimoto RA., Brannigan BW et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine, 2004;350(21), 2129-2139. https://doi.org/10.1056/ NEJMoa040938
Olivier M, Hollstein M, and Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspectives in Biology, 2010;2(1), a001008. https://doi.org/10.1101/cshperspect.a001008
Ang L, Chan CPY, Yau WP, Seow WJ. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis. Lung Cancer [Internet]. 2020;148 (June):129–37. Available from: https://doi.org/10.1016/j.lungcan.2020.08.012
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ [Internet]. 2009;339. Available from: https://www.bmj.com/content/339/bmj.b2535
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep;327 (7414):557–60.
Gao Y, Goldstein AM, Consonni D, Pesatori AC, Wacholder S, Tucker MA, et al. Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J cancer. 2009 Jul;125(1):146–52.
Zhao JK, Wu M, Kim CH, Jin ZY, Zhou JY, Han RQ, et al. Jiangsu Four Cancers Study: a large case-control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China. Eur J Cancer Prev Off J Eur Cancer Prev Organ. 2017 Jul;26(4):357–64.
Lissowska J, Foretova L, Dabek J, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Family history and lung cancer risk: an international multicentre case-control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control. 2010 Jul;21(7):1091–104.
Liang D, Wang J, Li D, Shi J, Jing J, Shan B, et al. Lung Cancer in Never-Smokers: A Multicenter Case-Control Study in North China. Front Oncol. 2019;9:1354.
Giacomazzi J, Ziegelmann PK, da Costa S, Bittar CM, Obst FM, Rosset C, et al. Cancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Study. JCO Glob Oncol. 2023 Sep;9:e2300006.
Gu J, Hua F, Zhong D, Chen J, Liu H, Zhou Q. [Systematic review of the relationship between family history of lung cancer and lung cancer risk]. Zhongguo Fei Ai Za Zhi. 2010 Mar;13(3):224–9.
Chattopadhyay S, Hemminki O, Försti A, Sundquist K, Sundquist J, Hemminki K. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer. Prostate Cancer Prostatic Dis [Internet]. 2019;22(1): 143–9. Available from: https://doi.org/ 10.1038/s41391-018-0089-y
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. Vol. 10, Journal of Thoracic Oncology : official publication of the International Association for the Study of Lung Cancer. United States; 2015. p. 1243–60.
Liu P, Vikis HG, Wang D, Lu Y, Wang Y, Schwartz AG, et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. J Natl Cancer Inst. 2008 Sep; 100(18):1326–30.
Brentnall TA. Management strategies for patients with hereditary pancreatic cancer. Curr Treat Options Oncol. 2005 Sep;6(5):437–45.
Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2024. Copyright 2024 Ottawa Hospital Research Institute.
